KMT2A and acute lymphoblastic leukemia: Together, these data show that a CRISPR-Cas9-induced t(4;11)/MLL-AF4 translocation in human FL HSPCs is sufficient to promote a rapidly progressive, fatal, transplantable B-ALL that recapitulates key features of infant-ALL.